We are live on
!
Find out more
RCM
Revelation Capital Management Portfolio holdings
AUM
$67.4M
This Fund
S&P 500
This Quarter
Est. Return
-41.25%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$27.4M
AUM Growth
-$76.3M
(-74%)
Cap. Flow
-$40.3M
Cap. Flow
% of AUM
-147.19%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
3
Closed
3
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
OMIC
Singular Genomics Systems, Inc. Common Stock
OMIC
|
+$23.1M |
| 2 |
ME
23andMe Holding Co
ME
|
+$9.13M |
| 3 |
SLGC
SomaLogic, Inc. Class A Common Stock
SLGC
|
+$4.32M |
| 4 |
Neuropace
NPCE
|
+$2.47M |
| 5 |
Natera
NTRA
|
+$739K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OMIC
1
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $14M | 51.22% |
73,998
-100,000
| -57% | -$23.1M |
|
|
ME
2
DELISTED
23andMe Holding Co
ME
| $10.2M | 37.36% |
133,387
-100,000
| -43% | -$9.13M |
|
|
3
Neuropace
NPCE
$522M
| $3.13M | 11.43% |
380,705
-285,835
| -43% | -$2.47M |
|
4
CVRx
CVRX
$131M
| – | – |
-38,182
| Closed | -$467K |
|
|
5
Natera
NTRA
$36.1B
| – | – |
-7,923
| Closed | -$739K |
|
|
SLGC
6
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| – | – |
-370,839
| Closed | -$4.32M |
|
Similar funds
RC
MA
S4W
SGOM
VIM
ILCM
FWA
EVC
Revelation Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, Revelation Capital Management held 6 positions worth $27.4M, down 74% from $104M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Revelation Capital Management withdrew a net $40.3M in Q1 2022, closing 3 positions and reducing 3 holdings. Its most notable exit was SomaLogic, Inc. Class A Common Stock, an estimated $4.32M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Revelation Capital Management's biggest Q1 2022 reduction was Singular Genomics Systems, Inc. Common Stock, cutting an estimated $23.1M.
- Revelation Capital Management fully exited SomaLogic, Inc. Class A Common Stock in Q1 2022, selling an estimated $4.32M.
- Revelation Capital Management's ten largest holdings make up 100% of its $27.4M portfolio in Q1 2022.
- Revelation Capital Management opened 0 new positions and closed 3 in Q1 2022.
- Revelation Capital Management's portfolio value fell 74% quarter-over-quarter to $27.4M.
Based on Revelation Capital Management's 13F filing for Q1 2022, filed 12 May 2022.